Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial

Pilger, E.; Pabst, E.; Kostner, G.; Wautrecht, J.; Baitsch, G.; Breddin, K.; Diehm, C.; Podhaisky, H.; Taute, B.; Diamantoupolos, E.; Aimar, T.; Alari, G.; Albano, S.; Altamura, N.; Arosio, E.; Bortolon, M.; Caccia, R.; Carotta, M.; Carzaniga, G.; Catalano, M.; Contini, P.; Difolca, A.; Dore, M.; Fabris, F.; Falaschi, F.; Franchini, B.; Frare, C.; Frascisco, M.; Giansante, C.; Giona, E.; Giubbolini, M.; Lucarelli, F.; Marchitelli, E.; Marcialis, M.; Martignoni, A.; Melillo, E.; Minola, M.; Monetti, D.; Nenci, G.; Paolicelli, M.; Pasqualini, L.; Perilli, E.; Pettina, G.; Poli, L.; Radicchia, S.; Rossi, M.; Scandale, G.; Scondotto, G.; Sergi, D.; Setacci, C.; Spada, S.; Todini, A.; Vaudo, G.; Verlato, F.; Visona, A.; Zannoni, M.; Bielawiec, M.; Jawien, A.; Meissner, A.; Michalak, J.; Nizankowski, R.; Wandzilak, M.; Avram, J.; Avram, R.; Hancu, N.; Marian, A.; Marian, I.; Murariu, M.; Negrisanu, G.; Olinic, D.; Olinic, N.; Trambitas, R.; Veresiu, I.; Victoria, I.; Kozak, M.; Mavri, A.; Bahi, J.; Bahi, P.; Brunkwall, J.; Gallino, A.

doi:10.1111/j.1365-2796.2006.01763.x

Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial

Atıf İçin Kopyala

Pilger E., Pabst E., Kostner G., Wautrecht J. C., Baitsch G., Breddin K., ...Daha Fazla

JOURNAL OF INTERNAL MEDICINE, cilt.261, sa.3, ss.276-284, 2007 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 261 Sayı: 3
Basım Tarihi: 2007
Doi Numarası: 10.1111/j.1365-2796.2006.01763.x
Dergi Adı: JOURNAL OF INTERNAL MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.276-284
Anahtar Kelimeler: antioxidant vitamins, aspirin, peripheral arterial disease, prevention, CARDIOVASCULAR EVENTS, VITAMIN-E, SUPPLEMENTATION
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Objective. To assess the prophylactic efficacy of aspirin and a high-dose antioxidant vitamin combination in patients with peripheral arterial disease (PAD) in terms of reduction of the risk of a first vascular event (myocardial infarction, stroke, vascular death) and critical limb ischaemia.